Roth Sample Clauses

Roth. 10-508981 Japan The Board of Regents of The University of Texas System APP 7/30/1996 7/24/1997 T. Mulchopadhyay; J. Roth 6133416 United States The Board of Regents of The University of Texas System PAT 8/23/1996 8/22/1997 10/17/2000 Inhibition of cell growth by an anti-proliferative factor D. Wilson; M. Lapadat-Tapolsky; T. Timmons, J. Lee; B. Almond; J. Roth 6054467 United States Introgen Therapeutics, Inc. PAT 7/5/1996 7/5/1996 4/25/2000 Down-regulation of DNA repair to enhance sensitivity of p53 mediated suppression R. Gjerset 505400/1998 Japan Introgen Therapeutics, Inc. APP 7/5/1996 7/2/1997 R. Gjerset 6110744 United States The Board of Regents of The University of Texas System PAT 11/13/1996 11/12/1997 8/29/2000 Diminishing viral expression by promoter replacement B. Fang; J. Roth 6630344 United States The Board of Regents of The University of Texas System PAT 11/13/1996 8/29/2000 10/7/2003 B. Fang; J. Roth 7244671 United States The Board of Regents of The University of Texas System PAT 11/13/1996 10/2/2003 7/17/2007 B. Fang; J. Roth Schedule 1.1(a)(i) PAT/APP NO. COUNTRY OWNER TYPE EARLIEST PRIORITY DATE FILING DATE ISSUE DATE TITLE INVENTOR EP1724350 Europe The Board of Regents of The University of Texas System APP 11/30/1995 5/9/2006 G. Clayman 3588048 Japan The Board of Regents of The University of Texas System APP 11/30/1995 11/27/1996 G. Clayman 1998-0704074 Korea The Board of Regents of The University of Texas System APP 11/30/1995 11/27/1996 G. Clayman P-327009 Poland The Board of Regents of The University of Texas System PAT 11/30/1995 11/27/1996 3/31/2003 G. Clayman 08/758,033 United States The Board of Regents of The University of Texas System APP 11/30/1995 11/27/1996 G. Clayman 09/968,958 United States The Board of Regents of The University of Texas System APP 11/30/1995 10/1/2001 G. Clayman 11/200,527 United States The Board of Regents of The University of Texas System APP 11/30/1995 8/9/2005 G. Clayman Schedule 1.1(a)(i) PAT/APP NO. COUNTRY OWNER TYPE EARLIEST PRIORITY DATE FILING DATE ISSUE DATE TITLE INVENTOR 10/395,864 United States The Board of Regents of The University of Texas System APP 11/30/1995 3/24/2003 G. Clayman 6479285 United States The Board of Regents of The University of Texas System PAT 7/2/1997 7/1/1998 11/12/2002 p53 as a regulator of cell differentiation P. Vize; J. Wallingford
Sample 1Sample 2Sample 3
AutoNDA by SimpleDocs

Related to Roth

  • DEFERRAL CONTRIBUTIONS The Advisory Committee will allocate to each Participant's Deferral Contributions Account the amount of Deferral Contributions the Employer makes to the Trust on behalf of the Participant. The Advisory Committee will make this allocation as of the last day of each Plan Year unless, in Adoption Agreement Section 3.04, the Employer elects more frequent allocation dates for salary reduction contributions.

  • Rollover Contributions An amount which qualifies as a rollover contribution pursuant to the Federal Internal Revenue Code may be transferred to and paid under this contract as a contribution for a Participant. Prudential may require proof that the amount paid so qualifies.

  • Elective Deferrals An Employee will be eligible to become a Contributing Participant in the Plan (and thus be eligible to make Elective Deferrals) and receive Matching Contributions (including Qualified Matching Contributions, if applicable) after completing 1 (enter 0, 1 or any fraction less than 1) Years of Eligibility Service.

  • EMPLOYEE CONTRIBUTIONS [X] (a) Participants shall be permitted to make Elective Deferrals in any amount from 1 % up to 15 % of their Compensation. If (a) is applicable, Participants shall be permitted to amend their Salary Savings Agreements to change the contribution percentage as provided below:

  • Employer Profit Sharing Contributions An Employee will be eligible to become a Participant in the Plan for purposes of receiving an allocation of any Employer Profit Sharing Contribution made pursuant to Section 10 of the Adoption Agreement after completing ________ (enter 0, 1, 2 or any fraction less than 2)

  • Qualified Nonelective Contributions If the Employer, at the time of contribution, designates a contribution to be a qualified nonelective contribution for the Plan Year, the Advisory Committee will allocate that qualified nonelective contribution to the Qualified Nonelective Contributions Account of each Participant eligible for an allocation of that designated contribution, as specified in Section 3.04 of the Employer's Adoption Agreement. The Advisory Committee will make the allocation to each eligible Participant's Account in the same ratio that the Participant's Compensation for the Plan Year bears to the total Compensation of all eligible Participants for the Plan Year. The Advisory Committee will determine a Participant's Compensation in accordance with the general definition of Compensation under Section 1.12 of the Plan, as modified by the Employer in Sections 1.12 and 3.06 of its Adoption Agreement.

  • PARTICIPANT NONDEDUCTIBLE CONTRIBUTIONS The Plan: (Choose (a) or (b); (c) is available only with (b)) [X] (a) Does not permit Participant nondeductible contributions. [ ] (b) Permits Participant nondeductible contributions, pursuant to Section 14.04 of the Plan.

  • Participant Contributions If Participant contributions are permitted, complete (a), (b), and (c). Otherwise complete (d).

  • Deferral Account 3.1 Establishing and Crediting. The Company shall establish a Deferral Account on its books for the Director, and shall credit to the Deferral Account the following amounts:

  • Matching Contributions The Employer will make matching contributions in accordance with the formula(s) elected in Part II of this Adoption Agreement Section 3.01.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!